Vote Smart's Synopsis:

Vote to pass a bill that requires fentanyl-related substances be permanently placed as a class into schedule I of the Controlled Substances Act.

Highlights:

• Requires fentanyl-related substances be permanently placed as a class into schedule I of the Controlled Substances Act (Sec. 1-7).

• Defines a “schedule I controlled substance” as a drug, substance, or chemical that (Sec. 1-7).

• Has a high potential for abuse; 

• Has no currently accepted medical value; and 

• Is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

• Requires that under this bill offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term) (Sec.  1-7).

• Establishes a new, alternative registration process for certain schedule I research (Sec.  1-7).

• Amends and makes several other changes to registration requirements for conducting research with controlled substances, including (Sec.  1-7):

• Permitting a single registration for related research sites in certain circumstances,

• Waiving the requirement for a new inspection in certain situations, and

• Allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

• Establishes that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance (Sec.  1-7).

Full Bill Text

Vote Smart's Synopsis:

Vote to pass a bill that requires fentanyl-related substances be permanently placed as a class into schedule I of the Controlled Substances Act.

Highlights:

• Requires fentanyl-related substances be permanently placed as a class into schedule I of the Controlled Substances Act (Sec. 1-7).

• Defines a “schedule I controlled substance” as a drug, substance, or chemical that (Sec. 1-7).

• Has a high potential for abuse; 

• Has no currently accepted medical value; and 

• Is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

• Requires that under this bill offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term) (Sec.  1-7).

• Establishes a new, alternative registration process for certain schedule I research (Sec.  1-7).

• Amends and makes several other changes to registration requirements for conducting research with controlled substances, including (Sec.  1-7):

• Permitting a single registration for related research sites in certain circumstances,

• Waiving the requirement for a new inspection in certain situations, and

• Allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

• Establishes that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance (Sec.  1-7).

Full Bill Text

Vote Smart's Synopsis:

Vote to invoke cloture on a bill that requires fentanyl-related substances be permanently placed as a class into schedule I of the Controlled Substances Act.

Highlights:

• Requires fentanyl-related substances be permanently placed as a class into schedule I of the Controlled Substances Act (Sec. 1-7).

• Defines a “schedule I controlled substance” as a drug, substance, or chemical that (Sec. 1-7).

• Has a high potential for abuse; 

• Has no currently accepted medical value; and 

• Is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

• Requires that under this bill offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term) (Sec.  1-7).

• Establishes a new, alternative registration process for certain schedule I research (Sec.  1-7).

• Amends and makes several other changes to registration requirements for conducting research with controlled substances, including (Sec.  1-7):

• Permitting a single registration for related research sites in certain circumstances,

• Waiving the requirement for a new inspection in certain situations, and

• Allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

• Establishes that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance (Sec.  1-7).

Full Bill Text

Full Bill Text